280 related articles for article (PubMed ID: 32676599)
1. Role of SARS-CoV-2 in altering the RNA binding protein and miRNA directed post-transcriptional regulatory networks in humans.
Srivastava R; Daulatabad SV; Srivastava M; Janga SC
bioRxiv; 2020 Sep; ():. PubMed ID: 32676599
[TBL] [Abstract][Full Text] [Related]
2. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
Srivastava R; Daulatabad SV; Srivastava M; Janga SC
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993015
[TBL] [Abstract][Full Text] [Related]
3. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.
Enguita FJ; Leitão AL; McDonald JT; Zaksas V; Das S; Galeano D; Taylor D; Wurtele ES; Saravia-Butler A; Baylin SB; Meller R; Porterfield DM; Wallace DC; Schisler JC; Mason CE; Beheshti A
Theranostics; 2022; 12(8):3946-3962. PubMed ID: 35664076
[No Abstract] [Full Text] [Related]
4. Insights into the SARS-CoV-2-Mediated Alteration in the Stress Granule Protein Regulatory Networks in Humans.
Prasad K; Alasmari AF; Ali N; Khan R; Alghamdi A; Kumar V
Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832615
[TBL] [Abstract][Full Text] [Related]
5. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
Vishnubalaji R; Shaath H; Alajez NM
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
[TBL] [Abstract][Full Text] [Related]
6. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.
Yousefi H; Poursheikhani A; Bahmanpour Z; Vatanmakanian M; Taheri M; Mashouri L; Alahari SK
Biomed Pharmacother; 2020 Oct; 130():110548. PubMed ID: 33475497
[TBL] [Abstract][Full Text] [Related]
8. Integration of risk variants from GWAS with SARS-CoV-2 RNA interactome prioritizes FUBP1 and RAB2A as risk genes for COVID-19.
Shi W; Chen M; Pan T; Chen M; Cheng Y; Hao Y; Chen S; Tang Y
Sci Rep; 2023 Nov; 13(1):19194. PubMed ID: 37932299
[TBL] [Abstract][Full Text] [Related]
9. Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells.
Barbagallo D; Palermo CI; Barbagallo C; Battaglia R; Caponnetto A; Spina V; Ragusa M; Di Pietro C; Scalia G; Purrello M
Cell Mol Life Sci; 2022 Jan; 79(2):75. PubMed ID: 35039944
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology.
Morales L; Oliveros JC; Enjuanes L; Sola I
mBio; 2022 Apr; 13(2):e0313521. PubMed ID: 35229638
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection severity and mortality is modulated by repeat-mediated regulation of alternative splicing.
Mehta P; Chattopadhyay P; Ravi V; Tarai B; Budhiraja S; Pandey R
Microbiol Spectr; 2023 Aug; 11(5):e0135123. PubMed ID: 37604131
[TBL] [Abstract][Full Text] [Related]
13. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
14. An in silico pipeline approach uncovers a potentially intricate network involving spike SARS-CoV-2 RNA, RNA vaccines, host RNA-binding proteins (RBPs), and host miRNAs at the cellular level.
Chetta M; Tarsitano M; Oro M; Rivieccio M; Bukvic N
J Genet Eng Biotechnol; 2022 Sep; 20(1):129. PubMed ID: 36066672
[TBL] [Abstract][Full Text] [Related]
15. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.
Merino GA; Raad J; Bugnon LA; Yones C; Kamenetzky L; Claus J; Ariel F; Milone DH; Stegmayer G
Bioinformatics; 2021 Apr; 36(24):5571-5581. PubMed ID: 33244583
[TBL] [Abstract][Full Text] [Related]
16. miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery.
Alam T; Lipovich L
Noncoding RNA; 2021 Mar; 7(1):. PubMed ID: 33801496
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
Front Immunol; 2022; 13():918692. PubMed ID: 36059456
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
Nambou K; Anakpa M
Infect Genet Evol; 2020 Nov; 85():104471. PubMed ID: 32707288
[TBL] [Abstract][Full Text] [Related]
19. Epitranscriptomic
Phillips S; Mishra T; Khadka S; Bohan D; Espada CE; Maury W; Wu L
Microbiol Spectr; 2023 Feb; 11(1):e0394322. PubMed ID: 36625663
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
